Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for chronic pelvic pain of uterine origin
2020-006147-25Phase 3Active
- Sponsor
- Centre de Recherche en Santé de la Femme
- Start
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in chronic prostatitis (CP), pelvic pain, dysmenorrhea and 1 more, sponsored by Centre de Recherche en Santé de la Femme. Primary endpoint: Patient Global Impression of Improvement (PGI-I). Started Jun 2024; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
chronic prostatitis (CP)pelvic paindysmenorrheadyspareunia
Beyond the preview
Go deeper on 2020-006147-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-006147-25.